Organization
Tris Pharma
4 clinical trials
Clinical trial
Randomized, Double-blind, Four Period, Six-treatment, Double-dummy, Placebo Controlled, Partial-crossover Study to Explore and Compare the Ventilatory Response to Hypercapnia (VRH) of Cebranopadol, Oxycodone, and Placebo in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-03-30
Clinical trial
Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHDStatus: Completed, Estimated PCD: 2019-10-19
Clinical trial
A Double-Blind, Randomized, Crossover Study to Assess the Abuse Potential of Intranasal Cebranopadol Compared to Oxycodone and Placebo in Healthy, Nondependent Recreational Opioid UsersStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy and Safety of Cebranopadol for the Treatment of Moderate to Severe Acute Pain After Primary Unilateral BunionectomyStatus: Not yet recruiting, Estimated PCD: 2024-11-01